Send the following on WhatsApp
Continue to ChatPARP 抑制劑聯合鉑類化療,有望改善類 BRCA 乳腺癌患者無惡化存活期? https://geneonline.news/parp-inhibitor-veliparib-brca-tnbc/?variant=zh-cn
PARP 抑制劑聯合鉑類化療,有望改善類 BRCA 乳腺癌患者無惡化存活期? https://geneonline.news/parp-inhibitor-veliparib-brca-tnbc/?variant=zh-cn